Compounds > valine

valine and Ovarian Neoplasms

valine has been researched along with Ovarian Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aghajanian, C; Berger, MF; Dao, F; Delair, D; Garg, K; Grisham, RN; Hyman, DM; Iasonos, A; Iyer, G; Levine, DA; Solit, DB; Spriggs, DR; Zhou, Q1
Aktas, D; Alikasifoglu, M; Ayhan, A; Guney, I; Tuncbilek, E; Yüce, K1
Chan, KY; Cheung, AN; Khoo, US; Ko, HH; Lai, TW; Yip, SP1
Chen, X; Chenevix-Trench, G; Johnatty, SE; Nagle, CM; Spurdle, AB; Webb, PM1
Chen, X; Chenevix-Trench, G; Green, A; Purdie, DM; Spurdle, AB; Webb, PM1
Hanjani, P; Subba Rao, G1

Other Studies

6 other study(ies) available for valine and Ovarian Neoplasms

ArticleYear
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
    Cancer, 2013, Feb-01, Volume: 119, Issue:3

    Topics: Aged; Amino Acid Substitution; Biomarkers, Tumor; Cystadenoma, Serous; Early Detection of Cancer; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Middle Aged; Mutation, Missense; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins B-raf; Survival Analysis; Valine

2013
CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
    Gynecologic oncology, 2002, Volume: 86, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adult; Alleles; Carcinoma; Case-Control Studies; Confidence Intervals; Cystadenocarcinoma; Cytochrome P-450 CYP1A1; Female; Genotype; Humans; Incidence; Isoleucine; Middle Aged; Odds Ratio; Ovarian Neoplasms; Polymerase Chain Reaction; Polymorphism, Genetic; Risk; Turkey; Valine

2002
Population-based case-control study of HER2 genetic polymorphism and breast cancer risk.
    Journal of the National Cancer Institute, 2002, Oct-16, Volume: 94, Issue:20

    Topics: Alleles; Asian People; Breast Neoplasms; Case-Control Studies; China; Female; Genes, erbB-2; Genotype; Hong Kong; Humans; Incidence; Isoleucine; Middle Aged; Molecular Epidemiology; Ovarian Neoplasms; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Assessment; Valine

2002
The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia).
    Gynecologic oncology, 2007, Volume: 107, Issue:3

    Topics: Adult; Alanine; Antioxidants; Australia; Case-Control Studies; Diet; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Ovarian Neoplasms; Polymorphism, Genetic; Superoxide Dismutase; Valine

2007
No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer.
    Carcinogenesis, 2001, Volume: 22, Issue:5

    Topics: Base Sequence; Case-Control Studies; DNA Primers; Exons; Female; Genetic Heterogeneity; Humans; Leucine; Odds Ratio; Ovarian Neoplasms; Point Mutation; Polymorphism, Genetic; Receptors, Progesterone; Valine

2001
Secretion of a 97 kilodalton glycoprotein by primary cultures of human ovarian epithelial tumor cells.
    Cancer letters, 1986, Volume: 33, Issue:3

    Topics: Carcinoma; Cells, Cultured; Female; Fibroblasts; Fucose; Glycoproteins; Humans; Molecular Weight; Ovarian Neoplasms; Valine

1986